Stoneridge Investment Partners LLC Nektar Therapeutics Transaction History

Stoneridge Investment Partners LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 28, 2020	SELL	$16.59 - $24.79 $455,213 - $680,212	-27,439 Closed	0 $0
Q2 2020 Aug 05, 2020	SELL	$16.86 - $23.44 $99,474 - $138,296	-5,900 Reduced 17.7%	27,439 $635,000
Q4 2019 Jan 29, 2020	SELL	$15.87 - $23.12 $12,696 - $18,496	-800 Reduced 2.34%	33,339 $720,000
Q3 2019 Oct 30, 2019	SELL	$16.91 - $36.27 $37,844 - $81,172	-2,238 Reduced 6.15%	34,139 $622,000
Q2 2019 Jul 29, 2019	BUY	$31.0 - $36.3 $1.13 Million - $1.32 Million	36,377 New	36,377 $1.29 Million

Q4 2017 Feb 05, 2018	SELL	$23.02 - $60.5 $248,708 - $653,642	-10,804 Closed	0 $0
Q3 2017 Nov 02, 2017	BUY	$17.79 - $24.0 $192,203 - $259,296	10,804	10,804 $259,000

128

111M

150K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $231M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Stoneridge Investment Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Stoneridge Investment Partners LLC with notifications on news.